Equities researchers at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Saturday. The brokerage set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Price Performance
CALA stock opened at $0.02 on Friday. The business has a 50 day moving average of $0.02 and a 200 day moving average of $0.02. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.13.
Calithera Biosciences Company Profile
Further Reading
- Five stocks we like better than Calithera Biosciences
- P/E Ratio Calculation: How to Assess Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 3 Healthcare Dividend Stocks to Buy
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- 3 Warren Buffett Stocks to Buy Now
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.